On December 11, 2024, Valsoft Corporation Inc., a Canadian company specializing in acquiring and developing vertical market software businesses, announced its acquisition of Exeevo, a CRM platform tailored for the Life Sciences sector. The deal closed on the same day. The acquisition marked Valsoft’s entry into the $20 billion Life Sciences software market, aligning with its strategy to invest in mission-critical software solutions.

Exeevo, built on Microsoft technology, empowers pharmaceutical, biotech, and medical device organizations with AI-driven tools for streamlined operations, predictive analytics, and enhanced stakeholder engagement. The leadership team at Exeevo will remain in place to drive innovation and customer support.

Valsoft was represented internally by David Felissimo (General Counsel), Oliver Gray (Senior Legal Counsel), and Pamela Romero (Paralegal), while Exeevo was advised by Rock Creek Advisor LLC (financial advisor) and Seyfarth LLP (legal counsel). Transaction value was not disclosed.